Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Kasahara K, Shibata K, Shintani H, Iwasa K, Sone T, Kimura H, Nobata K, Hirose T, Yoshimi Y, Katayama N, Ishiura Y, Kita T, Nishi K, Nakatsumi Y, Ryoma Y, Fujimura M, Nakao S.
Kasahara K, et al. Among authors: kimura h.
Anticancer Res. 2006 Mar-Apr;26(2B):1495-9.
Anticancer Res. 2006.
PMID: 16619563
Free article.
Clinical Trial.